1. Home
  2. ASNS vs PHIO Comparison

ASNS vs PHIO Comparison

Compare ASNS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • PHIO
  • Stock Information
  • Founded
  • ASNS 1998
  • PHIO 2011
  • Country
  • ASNS United States
  • PHIO United States
  • Employees
  • ASNS N/A
  • PHIO N/A
  • Industry
  • ASNS Telecommunications Equipment
  • PHIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASNS Telecommunications
  • PHIO Health Care
  • Exchange
  • ASNS Nasdaq
  • PHIO Nasdaq
  • Market Cap
  • ASNS 9.8M
  • PHIO 8.0M
  • IPO Year
  • ASNS 2022
  • PHIO N/A
  • Fundamental
  • Price
  • ASNS $1.09
  • PHIO $1.67
  • Analyst Decision
  • ASNS Strong Buy
  • PHIO Strong Buy
  • Analyst Count
  • ASNS 1
  • PHIO 1
  • Target Price
  • ASNS $5.00
  • PHIO $36.00
  • AVG Volume (30 Days)
  • ASNS 254.5K
  • PHIO 981.0K
  • Earning Date
  • ASNS 03-25-2025
  • PHIO 04-01-2025
  • Dividend Yield
  • ASNS N/A
  • PHIO N/A
  • EPS Growth
  • ASNS N/A
  • PHIO N/A
  • EPS
  • ASNS N/A
  • PHIO N/A
  • Revenue
  • ASNS $7,715,000.00
  • PHIO N/A
  • Revenue This Year
  • ASNS $76.45
  • PHIO N/A
  • Revenue Next Year
  • ASNS $25.80
  • PHIO N/A
  • P/E Ratio
  • ASNS N/A
  • PHIO N/A
  • Revenue Growth
  • ASNS 8.31
  • PHIO N/A
  • 52 Week Low
  • ASNS $0.36
  • PHIO $1.53
  • 52 Week High
  • ASNS $4.60
  • PHIO $10.35
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 34.86
  • PHIO 42.10
  • Support Level
  • ASNS $1.17
  • PHIO $1.64
  • Resistance Level
  • ASNS $1.26
  • PHIO $1.88
  • Average True Range (ATR)
  • ASNS 0.08
  • PHIO 0.13
  • MACD
  • ASNS -0.02
  • PHIO -0.02
  • Stochastic Oscillator
  • ASNS 0.00
  • PHIO 5.61

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The Company operates as one operating segment developing and marketing access broadband equipment for copper and fiber networks.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: